Co-treatment with Fexofenadine and Budesonide Increases FoxP3 Gene Expression in Patients with Allergic Rhinitis.

Elham BagheriniaSara FalahiSeyed Hamidreza MortazaviFarhad SalariAlireza RezaiemaneshAli Gorgin Karaji

Published in: American journal of rhinology & allergy (2023)

Our results showed that combined treatment with fexofenadine and budesonide increased the expression level of the FoxP3 gene, decreased the percentage of peripheral blood eosinophils, and improved the clinical symptoms of AR patients. This regimen appears to improve disease symptoms, at least in part by increasing the Treg population and decreasing the eosinophil population.

Keyphrases

gene expression
peripheral blood
allergic rhinitis
regulatory t cells
end stage renal disease
ejection fraction
chronic kidney disease
dna methylation
newly diagnosed
poor prognosis
sleep quality
physical activity
peritoneal dialysis
depressive symptoms
combination therapy
smoking cessation